ReviewSeminars in nuclear medicine2021
Variants and Pitfalls in PET/CT Imaging of Gastrointestinal Cancers.
Review in Seminars in nuclear medicine, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 36 papers, 1 of them a synthesis that pooled it.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
36 citing papers in PubMed, 1 synthesis or guideline pooled it, 52 citations in OpenAlex.
- [European journal of medical research · 2023Pooled it
- Comparison of metabolic variables in FDG PET/CT in rectal cancer patients who achieved a complete or incomplete response following neoadjuvant chemoradiotherapy.Annals of nuclear medicine · 2026Article
- Stomach and beyond: imaging the linitis plastica phenotype in signet ring cell carcinoma.Abdominal radiology (New York) · 2026Review
- Multifocal Peritoneal Mucinous Carcinoma Presenting as Small Bowel Obstruction: A Case Report.Cureus · 2026Article
- Fibroblast Activation Protein Inhibitor (FAPI) PET: A Scoping Review of Emerging Oncologic and Fibroinflammatory Applications.Diagnostics (Basel, Switzerland) · 2026Review
- The role of [⁶⁸Ga]Ga-FAP-2286 PET/CT in the evaluation of treatment response in gastrointestinal system malignancies.European journal of nuclear medicine and molecular imaging · 2026Article
- Segmental Colitis Associated with Diverticulosis: Status Quo.Journal of clinical medicine · 2026Review
- Clinical characteristics and long-term prognosis of primary mucosa-associated lymphoid tissue lymphoma and diffuse large B-cell lymphoma in the small intestine.Translational cancer research · 2025Article
- Colonic Epstein-Barr virus mucocutaneous ulcer mimicking metastatic cancer: a diagnostic pitfall on PET/CT in immunosuppressed patients.BJR case reports · 2025Article
- Gastric Metastases From Invasive Breast Lobular Carcinoma, Identified by [Clinical case reports · 2025Article
- Extensive bone metastases from an occult gastric primary: A case report.World journal of gastrointestinal oncology · 2025Article
- Enterocolitis associated with glofitamab-First report and clinicopathological findings in three cases.British journal of haematology · 2025Article
- In Vivo Interrogation of Cell-Penetrating Peptide Function: Accumulation in Tumors and the Potential as a Specific PET Probe.Bioconjugate chemistry · 2025Article
- The Many Faces of Intestinal Tumors in Adults, Including the Primary Role of CT Imaging in Emergencies and the Important Role of Cross-Sectional Imaging: A Pictorial Review.Healthcare (Basel, Switzerland) · 2025Review
- Updates in the Role of Positron Emission Tomography/Computed Tomography in Radiation Oncology in Gastrointestinal Malignancies.PET clinics · 2025Review
- Prediction of pathological response to neoadjuvant immunochemotherapy with baseline and post-treatmentBMC cancer · 2025Article
- Impact ofMolecular imaging and radionuclide therapy · 2025Article
- Evaluation ofAmerican journal of nuclear medicine and molecular imaging · 2025Article
- Metastatic mediastinal malignant tumors of gastrointestinal origin with occult primary lesions: a case report.Frontiers in oncology · 2025Article
- Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
3 authors at 1 institution in 1 country.
Funding
Abstract
In the past two decades, PET/CT has become an essential modality in oncology increasingly used in the management of gastrointestinal (GI) cancers. Most PET/CT tracers used in clinical practice show some degree of GI uptake. This uptake is quite variable and knowledge of common patterns of biodistribution of various radiotracers is helpful in clinical practice.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.